Regenxbio IncNASDAQ:RGNX
- LAST PRICE13.1500
- TODAY'S CHANGE (%)-0.4300 (-3.1664%)
- Bid / Lots13.1500/ 7
- Ask / Lots14.5000/ 4
- Open / Previous Close13.7400 / 13.5800
- Day Range
- 52 Week Range
- Volume957,990
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RGNX |
|---|---|---|
| 09:32 ET | 50991 | 13.45 |
| 09:34 ET | 3775 | 13.265 |
| 09:36 ET | 4891 | 13.16 |
| 09:38 ET | 21361 | 13.4 |
| 09:39 ET | 16125 | 13.245 |
| 09:41 ET | 12508 | 13.48 |
| 09:43 ET | 900 | 13.43 |
| 09:45 ET | 1600 | 13.445 |
| 09:48 ET | 1822 | 13.58 |
| 09:50 ET | 1385 | 13.661 |
| 09:52 ET | 380 | 13.66 |
| 09:54 ET | 900 | 13.53 |
| 09:56 ET | 2312 | 13.52 |
| 09:59 ET | 485 | 13.46 |
| 10:01 ET | 700 | 13.44 |
| 10:03 ET | 1950 | 13.36 |
| 10:06 ET | 1374 | 13.29 |
| 10:08 ET | 3086 | 13.37 |
| 10:10 ET | 400 | 13.435 |
| 10:12 ET | 400 | 13.4135 |
| 10:14 ET | 400 | 13.43 |
| 10:15 ET | 1172 | 13.48 |
| 10:17 ET | 4198 | 13.465 |
| 10:19 ET | 2285 | 13.39 |
| 10:21 ET | 1148 | 13.33 |
| 10:24 ET | 3060 | 13.3502 |
| 10:26 ET | 400 | 13.32 |
| 10:28 ET | 2740 | 13.21 |
| 10:30 ET | 1605 | 13.185 |
| 10:32 ET | 3397 | 13.205 |
| 10:33 ET | 1769 | 13.13 |
| 10:35 ET | 15947 | 12.99 |
| 10:37 ET | 1700 | 13.11 |
| 10:39 ET | 800 | 13.14 |
| 10:42 ET | 518 | 13.1 |
| 10:44 ET | 839 | 13.07 |
| 10:46 ET | 1150 | 13.12 |
| 10:48 ET | 900 | 13.1 |
| 10:50 ET | 200 | 13.12 |
| 10:51 ET | 1000 | 13.12 |
| 10:53 ET | 2804 | 13.25 |
| 10:55 ET | 1143 | 13.22 |
| 10:57 ET | 1300 | 13.2 |
| 11:00 ET | 900 | 13.23 |
| 11:02 ET | 700 | 13.315 |
| 11:04 ET | 2527 | 13.265 |
| 11:06 ET | 600 | 13.25 |
| 11:08 ET | 200 | 13.26 |
| 11:09 ET | 100 | 13.25 |
| 11:11 ET | 428 | 13.245 |
| 11:20 ET | 300 | 13.23 |
| 11:22 ET | 2323 | 13.24 |
| 11:24 ET | 400 | 13.27 |
| 11:26 ET | 2200 | 13.275 |
| 11:27 ET | 900 | 13.26 |
| 11:29 ET | 2810 | 13.28 |
| 11:31 ET | 13550 | 13.19 |
| 11:33 ET | 1000 | 13.22 |
| 11:36 ET | 1369 | 13.2 |
| 11:40 ET | 600 | 13.2 |
| 11:42 ET | 1700 | 13.2 |
| 11:44 ET | 725 | 13.18 |
| 11:45 ET | 1325 | 13.11 |
| 11:47 ET | 600 | 13.16 |
| 11:49 ET | 149 | 13.16 |
| 11:51 ET | 1700 | 13.155 |
| 11:54 ET | 300 | 13.145 |
| 11:56 ET | 1822 | 13.12 |
| 11:58 ET | 100 | 13.08 |
| 12:00 ET | 1000 | 13.13 |
| 12:03 ET | 1100 | 13.155 |
| 12:05 ET | 130 | 13.14 |
| 12:07 ET | 760 | 13.135 |
| 12:09 ET | 730 | 13.11 |
| 12:14 ET | 900 | 13.11 |
| 12:16 ET | 1300 | 13.11 |
| 12:18 ET | 996 | 13.1091 |
| 12:20 ET | 1525 | 13.08 |
| 12:21 ET | 100 | 13.04 |
| 12:23 ET | 300 | 13.055 |
| 12:25 ET | 1828 | 13.08 |
| 12:30 ET | 100 | 13.03 |
| 12:32 ET | 950 | 13.07 |
| 12:34 ET | 1069 | 13.04 |
| 12:36 ET | 1325 | 13.065 |
| 12:38 ET | 300 | 13.085 |
| 12:39 ET | 1169 | 13.06 |
| 12:41 ET | 100 | 13.0615 |
| 12:43 ET | 284 | 13.065 |
| 12:45 ET | 9387 | 12.96 |
| 12:48 ET | 466 | 12.95 |
| 12:50 ET | 100 | 12.92 |
| 12:52 ET | 1945 | 12.9605 |
| 12:54 ET | 410 | 12.914 |
| 12:56 ET | 1850 | 12.95 |
| 12:57 ET | 100 | 12.96 |
| 12:59 ET | 800 | 12.92 |
| 01:01 ET | 300 | 12.93 |
| 01:03 ET | 1549 | 12.96 |
| 01:06 ET | 452 | 12.94 |
| 01:08 ET | 450 | 12.94 |
| 01:10 ET | 221 | 12.93 |
| 01:12 ET | 2518 | 12.98 |
| 01:14 ET | 100 | 12.96 |
| 01:15 ET | 2800 | 12.9 |
| 01:17 ET | 740 | 12.91 |
| 01:19 ET | 1303 | 12.87 |
| 01:21 ET | 1499 | 12.9 |
| 01:24 ET | 921 | 12.87 |
| 01:28 ET | 200 | 12.88 |
| 01:30 ET | 1400 | 12.91 |
| 01:32 ET | 300 | 12.915 |
| 01:33 ET | 300 | 12.9 |
| 01:35 ET | 3542 | 12.97 |
| 01:37 ET | 400 | 12.9629 |
| 01:39 ET | 900 | 12.93 |
| 01:42 ET | 1700 | 12.975 |
| 01:44 ET | 700 | 12.97 |
| 01:46 ET | 700 | 12.9703 |
| 01:48 ET | 300 | 12.97 |
| 01:50 ET | 200 | 12.97 |
| 01:51 ET | 400 | 12.975 |
| 01:53 ET | 2421 | 12.95 |
| 01:57 ET | 919 | 12.93 |
| 02:02 ET | 2755 | 12.88 |
| 02:04 ET | 100 | 12.82 |
| 02:06 ET | 2300 | 12.86 |
| 02:08 ET | 450 | 12.8035 |
| 02:09 ET | 1700 | 12.83 |
| 02:11 ET | 1400 | 12.87 |
| 02:15 ET | 1100 | 12.88 |
| 02:18 ET | 702 | 12.926 |
| 02:20 ET | 300 | 12.902 |
| 02:22 ET | 620 | 12.89 |
| 02:24 ET | 562 | 12.89 |
| 02:26 ET | 2316 | 12.9401 |
| 02:27 ET | 2000 | 13.065 |
| 02:29 ET | 4500 | 13.11 |
| 02:31 ET | 4107 | 13.1 |
| 02:33 ET | 400 | 13.08 |
| 02:36 ET | 200 | 13.09 |
| 02:38 ET | 800 | 13.065 |
| 02:40 ET | 1524 | 13.13 |
| 02:42 ET | 712 | 13.08 |
| 02:44 ET | 200 | 13.0215 |
| 02:45 ET | 3100 | 13.035 |
| 02:47 ET | 1000 | 13.05 |
| 02:49 ET | 1800 | 13.041 |
| 02:51 ET | 900 | 13.06 |
| 02:54 ET | 2130 | 13.02 |
| 02:56 ET | 9833 | 13.02 |
| 02:58 ET | 3770 | 13.05 |
| 03:00 ET | 1913 | 13.03 |
| 03:02 ET | 1374 | 13.045 |
| 03:03 ET | 6811 | 13.03 |
| 03:05 ET | 1200 | 13.05 |
| 03:07 ET | 1100 | 13.09 |
| 03:09 ET | 1102 | 13.135 |
| 03:12 ET | 5680 | 13.065 |
| 03:14 ET | 600 | 13.042 |
| 03:16 ET | 2400 | 13.06 |
| 03:18 ET | 800 | 13.071 |
| 03:20 ET | 7006 | 13.075 |
| 03:21 ET | 2847 | 13.02 |
| 03:23 ET | 4835 | 13.03 |
| 03:25 ET | 3375 | 13.02 |
| 03:27 ET | 20398 | 12.87 |
| 03:30 ET | 9055 | 12.85 |
| 03:32 ET | 14844 | 12.82 |
| 03:34 ET | 8929 | 12.82 |
| 03:36 ET | 4974 | 12.82 |
| 03:38 ET | 8205 | 12.77 |
| 03:39 ET | 4763 | 12.8 |
| 03:41 ET | 1983 | 12.76 |
| 03:43 ET | 7514 | 12.79 |
| 03:45 ET | 4887 | 12.835 |
| 03:48 ET | 2312 | 12.83 |
| 03:50 ET | 2260 | 12.87 |
| 03:52 ET | 41125 | 12.91 |
| 03:54 ET | 6063 | 13.005 |
| 03:56 ET | 5346 | 13.02 |
| 03:57 ET | 10772 | 13.04 |
| 03:59 ET | 48636 | 13.15 |
Today
DJ Regenxbio Shifts CEO to Chairman, COO to Chief Executive, from 12 hours ago by Dow Jones
12 hours ago by Dow JonesREGENXBIO Announces Leadership Transition, from 12 hours ago by Dow Jones
12 hours ago by Dow JonesPress Release: REGENXBIO Announces Leadership Transition, from 12 hours ago by Dow Jones
12 hours ago by Dow Jones
Jun 7, 2024
DJ REGENXBIO Initiated at Buy by Goldman Sachs, from 7:38AM ET on Friday Jun 07, 2024 by Dow Jones
7:38AM ET on Friday Jun 07, 2024 by Dow Jones
Jun 5, 2024
REGENXBIO to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference, from 7:05AM ET on Wednesday Jun 05, 2024 by Dow Jones
7:05AM ET on Wednesday Jun 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Regenxbio Inc | 675.3M | -2.2x | --- |
SAGE Therapeutics Inc | 656.0M | -1.3x | --- |
Zymeworks Inc | 634.2M | -5.2x | --- |
Y-mAbs Therapeutics Inc | 529.7M | -24.2x | --- |
WAVE Life Sciences Ltd | 722.5M | -12.4x | --- |
Urogen Pharma Ltd | 461.4M | -3.8x | --- |
Company Information
REGENXBIO Inc. is a clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. The Company has developed a pipeline of gene therapy programs using its proprietary adeno-associated virus (AAV) gene therapy delivery platform (NAV Technology Platform) to address genetic diseases. The Company is focused on its internal development pipeline in three areas: retinal, neuromuscular and neurodegenerative diseases. Its investigational AAV therapeutics include ABBV-RGX-314, RGX-202 and RGX-121. It is developing ABBV-RGX-314 in collaboration with AbbVie to treat large patient populations impacted by wet age-related macular degeneration, diabetic retinopathy (DR) and other chronic retinal diseases characterized by loss of vision. It is developing RGX-202 to treat Duchenne muscular dystrophy (Duchenne). The Company is developing RGX-121 to treat Mucopolysaccharidosis type II (MPS II), a progressive, neurodegenerative lysosomal storage disorder.
Contact Information
- Headquarters
- 9804 Medical Center DriveROCKVILLE, MD, United States 20850
- Phone
- 240-552-8181
- Fax
- 302-655-5049
Executives
- Chairman of the Board
- Allan Fox
- President, Chief Executive Officer, Director
- Kenneth Mills
- Chief Financial Officer, Executive Vice President
- Vittal Vasista
- Chief Operating Officer, Executive Vice President
- Curran Simpson
- Executive Vice President, Chief Scientific Officer
- Olivier Danos
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $675.3M |
|---|---|
Revenue (TTM) | $86.7M |
Shares Outstanding | 49.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.29 |
EPS | $-5.88 |
Book Value | $7.08 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 7.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -306.52% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
